ENDRA Life Sciences (NDRA) Other Operating Expenses (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Other Operating Expenses for 11 consecutive years, with $5813.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Operating Expenses fell 91.56% year-over-year to $5813.0 in Q2 2026; TTM through Jun 2026 was $61736.0, a 79.91% decrease from a year earlier, with the FY2025 full-year figure at $189470.0, down 66.82% from the prior year.
• Other Operating Expenses was $5813.0 for Q2 2026 at ENDRA Life Sciences, up from $4278.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $420439.0 in Q3 2022 and troughed at $4278.0 in Q1 2026.
• A 5-year average of $167794.7 and a median of $155392.5 in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses soared 111.21% in 2022 and plunged 93.8% in 2026, its largest moves.
• Over 5 years, Other Operating Expenses stood at $326769.0 in 2022, then sank by 54.76% to $147833.0 in 2023, then plunged by 41.64% to $86271.0 in 2024, then tumbled by 92.63% to $6360.0 in 2025, then retreated by 8.6% to $5813.0 in 2026.
• The last three Other Operating Expenses figures came in at $5813.0 (Q2 2026), $4278.0 (Q1 2026), and $6360.0 (Q4 2025), per Business Quant data.